InFLAMES Corporate Corner – Immunoprofiling and Immunodrug Development

26 January 2023    
11:45 am - 6:00 pm
Visitor and Innovation Centre Joki
Lemminkäisenkatu 12 B, Turku, Finland

Welcome to the InFLAMES Research Flagship’s Corporate Corner titled Immunoprofiling and Immunodrug development.
In the event, you will hear the latest news of immunoprofiling and immunodrug development from company and research representatives. We have a great list of speakers from InFLAMES, Genomill, Auria Services, Aurlide, Orion, Misvik Biology, FICAN West, Valo Therapeutics and The Finnish Research Impact Foundation. In the end, the panel debate will discuss the promotion of industrial and academic cooperation. All interested parties are welcome.

The event starts with lunch at 11:45 and there is time for networking after the official programme at 16:00.

Please sign up by January 19th, 2023 at (Registration is closed).

Hosts of the event are Professor Riitta Lahesmaa, Turku Bioscience Centre, University of Turku and Professor of Practice Timo Veromaa, University of Turku

Preliminary Programme

11:45-12:15 Lunch (can be enjoyed during presentations)

Session chair: Professor of Practice Timo Veromaa

Opening words
Professor Riitta Lahesmaa, Turku Bioscience Centre, University of Turku

Enabling discoveries with single-cell and spatial omics
InFLAMES Group Leader Tapio Lönnberg
University of Turku

Drug discovery platform, what we have, what we need
Professor Olli Pentikäinen
Aurlide / University of Turku

Deciphering the immune system with computational tools
Professor Laura Elo
University of Turku

Highly scalable molecular diagnostics using next-generation DNA sequencing
CTO, Co-founder Manu Tamminen

Short info: Academy – Industry funding and possibilities
Research Manager Jarkko Koivunen and Research Manager Joe Hettinger, InFLAMES Research Flagship, University of Turku


Break (coffee/tea)

Session chair: Professor Riitta Lahesmaa

Novel Research Tools for Immuno-oncology Drug Discovery
Industrial PhD Researcher Kiesha Rice, Drug Research Doctoral Programme (DRDP), University of Turku
Misvik Biology

Auria Services
Real World Evidence through Auria Clinical Informatics
Client Service Manager Eeva Kronqvist, Auria Clinical Informatics
The samples and services of Auria Biobank
Data Analyst Roosa Kallionpää, Auria Biobank

Clinical cancer trial activities at Turku University Hospital
Director Pia Vihinen, FICAN West – Western Finland Cancer Centre

PeptiCRAd – adaptable intratumoral cancer immunotherapy platform for solid tumors
Chief Scientific Officer, Co-founder Sari Pesonen
Valo Therapeutics

Building the immuno-oncology drug discovery platform at Orion
Senior Scientist Reetta Virtakoivu
Orion Corporation

15:15 – 16:00

Panel discussion: How to improve academic-industry collaboration
Moderator: Professor of Practice Timo Veromaa

Director Pia Vihinen, FICAN West – Western Finland Cancer Centre
Senior Scientist Reetta Virtakoivu, Orion Corporation
CTO, Co-founder Manu Tamminen, Genomill
CEO Petro Poutanen, The Finnish Research Impact Foundation


Networking and drinks